Find your next paid study

An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With Atypical Hemolytic-Uremic Syndrome (aHUS Registry)

Post-marketing safety data on patients treated and untreated with eculizumab or ravulizumab.